Skip to main content
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. — Investor Relations & Filings

Ticker · RKDA ISIN · US0390142042 LEI · 54930027ZPNA80B8O763 US Agriculture, forestry and fishing
Open in API
Filings indexed 564 across all filing types
Latest filing 2017-08-10 Interim / Quarterly Rep…
Country US United States of America
Listing US RKDA

About Arcadia Biosciences, Inc.

https://arcadiabio.com/

Arcadia Biosciences, Inc. is a company focused on developing and marketing plant-based health and wellness products. With a foundation in agricultural innovation, the company cultivates next-generation ingredients and consumer goods. Its primary focus is a portfolio of specialty wheat ingredients designed to offer enhanced nutritional benefits, such as increased fiber, improved protein quality, reduced allergenic gluten, and higher amino acid content. Arcadia aims to transform wheat into a functional food ingredient, collaborating with food manufacturers to create healthier formulations of consumer products. In addition to its wheat ingredients, the company's brand portfolio includes Zola, a line of natural coconut water products.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q2 2017
2017-08-10 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K current report filed with the SEC. It includes two main items: Item 2.02 which announces the issuance of a press release with financial results for the second quarter ended June 30, 2017, and Item 5.02 which announces the appointment of a new director to the board. The document itself does not contain the full financial results or detailed financial statements but rather references a press release (Exhibit 99.1) that contains the financial results. The document also includes a board/management change announcement. Since the document is a current report (8-K) that primarily announces events (financial results release and director appointment) rather than providing the full financial report or detailed financial data, it fits best under the category of Board/Management Information (MANG) due to the director appointment, and also partly relates to Earnings Release (ER) because of the financial results announcement. However, the financial results are only referenced as a press release and not fully included, so the primary classification should be MANG because the director appointment is a substantive event detailed in the filing. The document length (6513 characters) supports that it is more than a brief announcement but not a full financial report. Therefore, the best classification is MANG with high confidence.
2017-08-10 English
FORM 4 SUBMISSION
Director's Dealing
2017-08-10 English
FORM 3 SUBMISSION
Director's Dealing
2017-08-10 English
FORM 4/A SUBMISSION
Director's Dealing
2017-06-16 English
FORM 4 SUBMISSION
Director's Dealing
2017-06-12 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.